154 related articles for article (PubMed ID: 38429784)
1. Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.
Tekpor E; Effah K; Sifa J; Amuah JE; Essel NOM; Kemawor S; Wormenor CM; Sesenu E; Danyo S; Akakpo PK
BMC Public Health; 2024 Mar; 24(1):659. PubMed ID: 38429784
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract][Full Text] [Related]
3. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
Temesgen MM; Alemu T; Shiferaw B; Legesse S; Zeru T; Haile M; Gelanew T
PLoS One; 2021; 16(3):e0248949. PubMed ID: 33760866
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
[TBL] [Abstract][Full Text] [Related]
6. Self-sampling and HPV DNA testing for cervical precancer screening in a cohort of nuns in Ghana: a cross-sectional cohort study.
Effah K; Tekpor E; Amuah JE; Essel NOM; Kemawor S; Catherine Morkli EA; Lamptey-Mills E; Wormenor CM; Manu LS; Klutsey GB; Danyo S; Akakpo PK
EClinicalMedicine; 2023 Sep; 63():102183. PubMed ID: 37692077
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with mental health of internal migrants (Kayayei) in Agbogbloshie-Ghana.
Komesuor J; Meyer-Weitz A
BMC Womens Health; 2023 Aug; 23(1):449. PubMed ID: 37626390
[TBL] [Abstract][Full Text] [Related]
8. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
9. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
[TBL] [Abstract][Full Text] [Related]
10. Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up.
Effah K; Tekpor E; Wormenor CM; Essel NOM; Kemawor S; Sesenu E; Danyo S; Kitcher YT; Klutsey GB; Tay G; Tibu F; Abankroh KA; Atuguba BH; Akakpo PK
Ecancermedicalscience; 2023; 17():1645. PubMed ID: 38414966
[TBL] [Abstract][Full Text] [Related]
11. Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana.
Effah K; Tekpor E; Wormenor CM; Amuah JE; Essel NO; Atuguba BH; Klutsey GB; Sesenu E; Tay G; Tibu F; Kemawor S; Gedzah I; Morkli EAC; Danyo S; Akakpo PK
PLOS Glob Public Health; 2023; 3(4):e0001830. PubMed ID: 37079498
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
Agyare Gyane F; Modey E; Maya E; Bonney EY; Abaidoo-Myles A; Paintsil E; Torpey K
PLoS One; 2024; 19(5):e0303535. PubMed ID: 38814956
[TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
15. Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana.
Dei-Adomakoh Y; Effah K; Tekpor E; Crabbe S; Amuah JE; Wormenor CM; Tay G; Asare EV; Kemawor S; Danyo S; Morkli EAC; Tibu F; Essel NO; Akakpo PK
Ecancermedicalscience; 2023; 17():1571. PubMed ID: 37533951
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
[TBL] [Abstract][Full Text] [Related]
17. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
[TBL] [Abstract][Full Text] [Related]
18. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
Krings A; Dunyo P; Pesic A; Tetteh S; Hansen B; Gedzah I; Wormenor CM; Amuah JE; Behnke AL; Höfler D; Pawlita M; Kaufmann AM
PLoS One; 2019; 14(6):e0218762. PubMed ID: 31246997
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
